Export 2757 results:
Author Title Type [ Year(Asc)]
2021
T. Etheridge, Dobson, E. T. A., Wiedenmann, M., Oden, N., VanVeldhuisen, P., Scott, I. U., Ip, M. S., Eliceiri, K. W., Blodi, B. A., and Domalpally, A., “Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.”, Transl Vis Sci Technol, vol. 10, no. 3, p. 31, 2021.
E. Ertin, Sugavanam, N., Holtyn, A. F., Preston, K. L., Bertz, J. W., Marsch, L. A., McLeman, B., Shmueli-Blumberg, D., Collins, J., King, J. S., McCormack, J., and Ghitza, U. E., “An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches”, Front Psychiatry, vol. 12, p. 674691, 2021.
L. Pauleikhoff, Heeren, T. F. C., Gliem, M., Lim, E., Pauleikhoff, D., Holz, F. G., Clemons, T., Balaskas, K., Egan, C. A., and Issa, P. Charbel, “Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.”, Am J Ophthalmol, vol. 228, pp. 27-34, 2021.
R. Bonelli, Ansell, B. R. E., Lotta, L., Scerri, T., Clemons, T. E., Leung, I., Peto, T., Bird, A. C., Sallo, F. B., Langenberg, C., and Bahlo, M., “Genetic Disruption of Serine Biosynthesis is a Key Driver of Macular Telangiectasia Type 2 Aetiology and Progression”, Genome Med, vol. 13, no. 1, p. 39, 2021.
D. R. Stevens, Grobman, W., Kumar, R., Lipsky, L. M., Hinkle, S. N., Chen, Z., Williams, A., Rohn, M. C. H., Kanner, J., Sherman, S., and Mendola, P., “Gestational and Postpartum Weight Trajectories Among Women With and Without Asthma.”, Am J Epidemiol, vol. 190, no. 5, 2021.
S. Morgello, Cortes, E. P., Gensler, G., Meloni, G., Jacobs, M. M., Murray, J., Borukov, V., and Crary, J. F., “HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.”, AIDS, 2021.
S. E. Frey, Stapleton, J. T., Ballas, Z. K., Rasmussen, W. L., Kaufman, T. M., Blevins, T., Jensen, T. L., D Davies, H., Tary-Lehman, M., Chaplin, P., Hill, H., and Goll, J. B., “Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses.”, J Infect Dis, 2021.
S. Sivapalasingam, Saviolakis, G. A., Kulcsar, K., Nakamura, A., Conrad, T., Hassanein, M., Sumner, G., Elango, C., Kamal, M. A., Eng, S., Kyratsous, C. A., Musser, B. J., Frieman, M., Kantrowitz, J., Weinreich, D. M., Yancopoulos, G., Stahl, N., and Lipsich, L., “Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV).”, J Infect Dis, 2021.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., “Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”, Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
M. Shahait, Liu, V. Y. T., Vapiwala, N., Lal, P., Kim, J., Trabulsi, E. J., Huang, H. - C., Davicioni, E., Thompson, D. J. S., Spratt, D., Den, R. B., and Lee, D. I., “Impact of Decipher on use of post-operative radiotherapy: Individual patient analysis of two prospective registries.”, BJUI Compass, 2021.
M. E. Horwitz, tiff, P., Rezvani, A. R., Hwang, W. Ying Khee, Karras, N., Valcarcel, D., Koh, L. Piu, yasser, K., Keating, A. K., Segalovich, I., Sanz, G., Cutler, C., Brunstein, C. G., Hanna, R., McGuirk, J. P., Lindemans, C. A., Maziarz, R. T., Schiller, G. J., Hammerschlak, N., Frankfurt, O., Blackwell, B., and Galamidi, E., “Improved Clinical Outcomes with Omidubicel versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter Study”. 2021.
A. A. Aref, Scott, I. U., VanVeldhuisen, P. C., King, J., Ip, M. S., Blodi, B. A., and Oden, N. L., “Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial”, JAMA Ophthalmol, vol. 139, no. 12, pp. 1285-1291, 2021.
R. Kondapaka, Vijayarangan, A., Henning, A., Kunwar, P., and Schlessman, K., “Leveraging patient profiles for routine pharmacovigilance in clinical trials”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B., “Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.”, Vaccine, vol. S0264-410X(20)31590, 2021.
A. M. Denicoff, S. Ivy, P., Worthington, K. H., Zhao, J., Seibel, N., Mishkin, G. E., Mooney, M. M., and Little, R. F., “National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria”, ASCO Annual Meeting 2021. 2021.
L. A. Devlin, Young, L. W., Kraft, W. K., Wachman, E. M., Czynski, A., Merhar, S. L., Winhusen, T., Jones, H. E., Poindexter, B. B., Wakschlag, L. S., Salisbury, A. L., Matthews, A. G., and Davis, J. M., “Neonatal Opioid Withdrawal Syndrome: A Review of the Science and a Look Toward the use of Buprenorphine for Affected Infants”, J Perinatol, vol. 42, no. 3, 2021.
L. J. Van Marter, Pennell, P. B., Brown, C., Hartman, A. L., May, R. C., McElrath, T., Ippolito, D., and Meador, K. J., “Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy.”, J Pediatr X, vol. 7, 2021.
L. J. Van Marter, Pennell, P., Brown, C., May, R., McElrath, T., Ippolito, D., and Meador, K. J., “Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy”, in Pediatric Academic Socities (PAS), 2021.
A. A. Pietraszkiewicz, Payne, D., Abraham, M., Garced, A., Devarasetty, K. C., Wall, M., Menezes, S. M., Ugarte, S., Pirsl, F., Goklemez, S., Ferris, F. L., Barrett, J., Battiwalla, M., Childs, R. W., Pavletic, S. Z., and Bishop, R. J., “Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.”, Bone Marrow Transplant, 2021.
M. E. Horwitz, Stiff, P. J., Cutler, C., Brunstein, C., Hanna, R., Maziarz, R. T., Rezvani, A. R., Karris, N. A., McGuirk, J., Valcarcel, D., Schiller, G. J., Lindemans, C. A., Hwang, W. Y. K., Koh, L. Piu, Keating, A., Khaled, Y., Hamerschlak, N., Frankfurt, O., Peled, T., Segalovich, I., Blackwell, B., Wease, S., Freedman, L. S., Galamidi-Cohen, E., and Sanz, G., “Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.”, Blood, vol. 138, no. 16, pp. 1429-1440, 2021.
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”, Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., “PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.”, PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
T. P. Lodise, Van Wart, S., Sund, Z. M., Bressler, A. M., Khan, A., Makley, A. T., Hamad, Y., Salata, R. A., Silveira, F. P., Sims, M. D., Kabchi, B. A., Saad, M. A., Brown, C., Oler, R. E., Fowler, V., and Wunderink, R. G., “Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).”, Antimicrob Agents Chemother, vol. 65, no. 3, 2021.
C. I. Campbell, Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., Bart, G., Schwartz, R. P., McNeely, J., Liebschutz, J. M., Tsui, J. I., Merrill, J. O., Glass, J. E., Lapham, G. T., Murphy, S. M., Weinstein, Z. M., Yarborough, B. Jo H., and Bradley, K. A., “PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.”, Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
A. G. Callahan, Coleman-Cowger, V. H., Schulkin, J., and Power, M. L., “Racial Disparities in Influenza Immunization During Pregnancy in the United States: A Narrative Review of the Evidence for Disparities and Potential Interventions”, Vaccine, vol. 39, no. 35, pp. 4938-4948, 2021.